| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 135.317 | 133.049 | 141.298 | 144.347 | 169.606 | 160.785 | 233.357 | 274.319 | 303.754 | 244.935 |
| Total Income - EUR | 135.592 | 133.049 | 142.220 | 146.278 | 169.608 | 160.785 | 233.521 | 274.319 | 303.834 | 244.935 |
| Total Expenses - EUR | 110.950 | 124.591 | 114.947 | 116.682 | 136.713 | 135.441 | 176.225 | 228.910 | 223.873 | 142.845 |
| Gross Profit/Loss - EUR | 24.642 | 8.458 | 27.273 | 29.595 | 32.895 | 25.343 | 57.296 | 45.409 | 79.962 | 102.090 |
| Net Profit/Loss - EUR | 21.403 | 7.039 | 24.698 | 28.136 | 31.180 | 24.100 | 55.126 | 43.420 | 77.470 | 94.889 |
| Employees | 4 | 3 | 3 | 3 | 2 | 2 | 2 | 3 | 4 | 5 |
Check the financial reports for the company - Ritus-Biotec Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 76.066 | 32.850 | 25.809 | 21.068 | 29.984 | 34.564 | 24.934 | 16.121 | 15.542 | 14.112 |
| Current Assets | 38.646 | 34.342 | 31.888 | 25.922 | 36.918 | 35.879 | 67.550 | 99.837 | 113.855 | 106.890 |
| Inventories | 3.463 | 838 | 3.312 | 2.048 | 0 | 0 | 0 | 0 | 0 | 5.536 |
| Receivables | 30.082 | 32.647 | 26.644 | 23.142 | 36.954 | 34.955 | 28.294 | 49.771 | 66.790 | 28.470 |
| Cash | 5.101 | 857 | 1.933 | 732 | -36 | 924 | 39.256 | 50.066 | 47.065 | 72.884 |
| Shareholders Funds | 40.203 | 31.245 | 37.901 | 37.620 | 48.984 | 54.953 | 84.270 | 96.019 | 91.377 | 99.142 |
| Social Capital | 225 | 223 | 219 | 215 | 211 | 207 | 202 | 203 | 202 | 201 |
| Debts | 74.511 | 35.949 | 19.798 | 9.370 | 17.918 | 15.490 | 8.214 | 19.938 | 38.020 | 21.860 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8691 - 8691" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Ritus-Biotec Srl